Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4032.00x is 24% below its 2-year average of -3246.91x, around the middle of its 2-year range (-7292.85x–-239.50x).
As of the fiscal period ended Friday, December 31, 2021. 34.97% below its 12-month average of -2987.27x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2021 (2021-12-31): -4032.00x.
INTEREST COVERAGE RATIO
-4032.00x
INTEREST COVERAGE RATIO AVG TTM
-2987.27x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-34.97%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-95219.15%
vs the sector median at left
Longeveron Inc.
Market Cap
$7.46M
Interest Coverage Ratio
-4032.00x
TTM Avg
-2987.27x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.31M
Interest Coverage Ratio
-924.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.78M
Interest Coverage Ratio
-11.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.06M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.22M
Interest Coverage Ratio
-185.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.89M
Interest Coverage Ratio
-1049.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.84M
Interest Coverage Ratio
-97.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.88M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Longeveron Inc. (LGVN) | $7.46M | -4032.00x | -2987.27x | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -924.78x | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $7.78M | -11.17x | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.06M | -496.55x | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.36M | -11.95x | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.22M | -185.05x | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.89M | -1049.68x | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $7.84M | -97.81x | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | N/A | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | N/A | N/A | N/A | N/A |
Interest Coverage
-4032.0x
Debt/Equity
0.06
Current Ratio
2.63
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | -4032.00x |
| 2021-09-30 | -4905.00x |
| 2021-06-30 | -2531.00x |
| 2020-12-31 | -481.09x |
| 2020-09-30 | -239.50x |
| 2019-12-31 | -7292.85x |
